Moreover, in an in vitro study using the HT-29 colon cancer model, PTS inhibited the transcriptional expression of augmented iNOS levels and moderated the inhibition of COX-2 in a concentration-dependent manner [40,89]. The gene discussed is NOS2; the disease is colonic neoplasm.